Suivre
Marta Rychert
Marta Rychert
Adresse e-mail validée de massey.ac.nz
Titre
Citée par
Citée par
Année
Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries
PJ Adams, M Rychert, C Wilkins
Addiction 116 (11), 2939-2946, 2021
302021
A critical analysis of the implementation of a legal regulated market for new psychoactive substances (“legal highs”) in New Zealand
M Rychert, C Wilkins
International Journal of Drug Policy 55, 88-94, 2018
302018
What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS,‘legal highs’)? Implications for law enforcement and penalties
M Rychert, C Wilkins
Drug Testing and Analysis 8 (8), 768-778, 2016
272016
“Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand
M Rychert, C Wilkins, K Witten
Drugs: education, prevention and policy 25 (3), 254-261, 2018
252018
A ‘community enterprise’model for recreational cannabis: lessons from alcohol licensing trusts in New Zealand
M Rychert, C Wilkins
International Journal of Drug Policy 67, 72-78, 2019
242019
Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?
C Wilkins, JS Romeo, M Rychert, J Prasad, T Graydon-Guy
International Journal of Drug Policy 61, 15-22, 2018
242018
Why did New Zealand's referendum to legalise recreational cannabis fail?
M Rychert, C Wilkins
Drug and alcohol review 40 (6), 877-881, 2021
232021
Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study
M Rychert, MA Emanuel, C Wilkins
Globalization and Health 17, 1-11, 2021
222021
Assessing New Zealand’s cannabis legalization and control bill: prospects and challenges
C Wilkins, M Rychert
Addiction 116 (2), 222-230, 2021
222021
Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS,‘legal highs’) in New Zealand
M Rychert, C Wilkins
International Journal of Drug Policy 37, 90-97, 2016
202016
Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory
M Rychert, C Wilkins
Addiction 113 (11), 2132-2139, 2018
192018
The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS)(‘legal highs’) in New Zealand: Issues and options …
M Rychert, C Wilkins
International Journal of Drug Policy 26 (12), 1273-1278, 2015
192015
Predictors of using social media to purchase drugs in New Zealand: Findings from a large-scale online survey
R van der Sanden, C Wilkins, JS Romeo, M Rychert, MJ Barratt
International Journal of Drug Policy 98, 103430, 2021
182021
Recent trends in illegal drug use in New Zealand, 2006-2014
C Wilkins, J Prasad, K Wong, M Rychert
Social and Health Outcomes Research and Evaluation, Massey University, 2015
182015
Exploring methamphetamine trends in Europe
J Mounteney, T Groshkova, D Thanki, A Cunningham, M Rychert
Publications Office, 2014
172014
Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (‘legal highs’) in New Zealand
M Rychert, C Wilkins, K Witten
Drug and Alcohol Review 36 (5), 589-596, 2017
162017
Recent developments with the New Zealand regulated market approach to ‘low‐risk’psychoactive products
C Wilkins, M Rychert
Addiction 112 (1), 34-36, 2017
162017
Recent trends in illegal drug use in New Zealand, 2006–2016: Findings from the Illicit Drug Monitoring System
C Wilkins, P Sweetsur, R Griffiths
Retrieved from Massey University, New Zealand, 2017
152017
Recent trends in illegal drug use in New Zealand, 2006-2013: findings from the 2006, 2007, 2008, 2009, 2010, 2011, 2012, and 2013 Illicit Drug Monitoring System
C Wilkins, J Prasad, KC Wong, M Rychert
Shore and Whariki Research Centre, 2014
142014
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study
E Wadsworth, V Rynard, P Driezen, TP Freeman, M Rychert, C Wilkins, ...
Harm reduction journal 20 (1), 19, 2023
132023
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20